CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 165 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02033382
NCT02033382N/ACompleted
CompareCT.gov

Biomarkers in First Episode Schizophrenia

NYU Langone Health·observational·Posted Jan 10, 2014·Updated Jan 14, 2021

In Brief

An observational study for Schizophrenia and 2 related conditions. Completed, enrolled 165 participants across 1 site.

Detailed Summary

This study will identify and evaluate relevant biomarkers and structural brain imaging for understanding potential biological illness related mechanisms in medication-naïve subjects with early psychosis before and after initiation of antipsychotic medication

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSchizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, Depressed Type
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 10, 2014
Enrollment StartJul 1, 2012
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 12.5 years ago